Blood pressure-related genes and the progression of IgA nephropathy

Nephron - Clinical Practice

Volumn 113, Issue 4, 2009, Pages

  Kim, Sun Moon ^a   Chin, Ho Jun ^a   Oh, Yun Kyu ^a   Kim, Yon Su ^a   Kim, Suhnggwon ^a   Lim, Chun Soo ^a  

^a Seoul National University   (South Korea)

Author keywords

Angiotensinogen; Gender; Genetic polymorphism; Hypertension; IgA nephropathy

Indexed keywords

ALDOSTERONE SYNTHASE; ALPHA ADDUCIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSINOGEN; ASPARAGINE; CYSTEINE; ENDOTHELIN 1; GLYCINE; LYSINE; METHIONINE; THREONINE; TRYPTOPHAN;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENDER; GENE EXPRESSION PROFILING; GENETIC RISK; GENOTYPE; HUMAN; HYPERTENSION; IMMUNOGLOBULIN A NEPHROPATHY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SOUTH KOREA;

ADULT; ANGIOTENSINS; COMORBIDITY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GLOMERULONEPHRITIS, IGA; HUMANS; HYPERTENSION; INCIDENCE; KOREA; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK ASSESSMENT; RISK FACTORS; SEX DISTRIBUTION;

EID: 69549112673     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000235948     Document Type: Article

References (32)

1. D'Amico G: Natural history of idiopathic IgA nephropathy and factors predictive of disease outcome. Semin Nephrol 2004; 24: 179-196.
2. Deenitchina SS, Shinozaki M, Hirano T, Ando T, Hirakata H, Kiyohara Y, Katafuchi R, Fujishima M: Association of a T-cell receptor constant alpha chain gene polymorphism with progression of IgA nephropathy in Japanese patients. Am J Kidney Dis 1999; 34: 279-288.
3. Shu KH, Lee SH, Cheng CH, Wu MJ, Lian JD: Impact of interleukin-1 receptor antagonist and tumor necrosis factor-alpha gene polymorphism on IgA nephropathy. Kidney Int 2000; 58: 783-789.
4. Pei Y, Scholey J, Thai K, Suzuki M, Cattran D: Association of angiotensinogen gene T235 variant with progression of immunoglobin A nephropathy in Caucasian patients. J Clin Invest 1997; 100: 814-820.
5. Song J, Narita I, Goto S, Saito N, Omori K, Sato F, Ajiro J, Saga D, Kondo D, Sakatsume M, Gejyo F: Gender specific association of aldosterone synthase gene polymorphism with renal survival in patients with IgA nephropathy. J Med Genet 2003; 40: 372-376.
6. Jeunemaitre X, Charru A, Chatellier G, Dumont C, Sassano P, Soubrier F, Menard J, Corvol P: M235T variant of the human angiotensinogen gene in unselected hypertensive patients. J Hypertens 1993; 11:S80-S81.
7. Frimat L, Philippe C, Maghakian MN, Jonveaux P, Hurault de Ligny B, Guillemin F, Kessler M: Polymorphism of angiotensin converting enzyme, angiotensinogen, and angiotensin II type 1 receptor genes and endstage renal failure in IgA nephropathy: IGARAS - a study of 274 men. J Am Soc Nephrol 2000; 11: 2062-2067.
8. Bonnardeaux A, Davies E, Jeunemaitre X, Fery I, Charru A, Clauser E, Tiret L, Cambien F, Corvol P, Soubrier F: Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension. Hypertension 1994; 24: 63-69.
9. Bantis C, Ivens K, Kreusser W, Koch M, Klein-Vehne N, Grabensee B, Heering P: Influence of genetic polymorphisms of the renin-angiotensin system on IgA nephropathy. Am J Nephrol 2004; 24: 258-267. (Pubitemid 38456637)
10. Delles C, Erdmann J, Jacobi J, Hilgers KF, Fleck E, Regitz-Zagrosek V, Schmieder RE: Aldosterone synthase (CYP11B2) -344 C/T polymorphism is associated with left ventricular structure in human arterial hypertension. J Am Coll Cardiol 2001; 37: 878-884.
11. Hautanen A, Toivanen P, Manttari M, Tenkanen L, Kupari M, Manninen V, Kayes KM, Rosenfeld S, White PC: Joint effects of an aldosterone synthase (CYP11B2) gene polymorphism and classic risk factors on risk of myocardial infarction. Circulation 1999; 100: 2213-2218.
12. Lovati E, Richard A, Frey BM, Frey FJ, Ferrari P: Genetic polymorphisms of the reninangiotensin-aldosterone system in end-stage renal disease. Kidney Int 2001; 60: 46-54.
13. Cusi D, Barlassina C, Azzani T, Casari G, Citterio L, Devoto M, Glorioso N, Lanzani C, Manunta P, Righetti M, Rivera R, Stella P, Troffa C, Zagato L, Bianchi G: Polymorphisms of alpha-adducin and salt sensitivity in patients with essential hypertension. Lancet 1997; 349: 1353-1357.
14. Narita I, Goto S, Saito N, Song J, Ajiro J, Sato F, Saga D, Kondo D, Akazawa K, Sakatsume M, Gejyo F: Interaction between ACE and ADD1 gene polymorphisms in the progression of IgA nephropathy in Japanese patients. Hypertension 2003; 42: 304-309.
15. Maixnerova D, Merta M, Reiterova J, Stekrova J, Rysava R, Obeidova H, Viklicky O, Potmesil P, Tesar V: The influence of three endothelin-1 polymorphisms on the progression of IgA nephropathy. Folia Biol (Praha) 2007; 53: 27-32.
16. Lee HS, Lee MS, Lee SM, Lee SY, Lee ES, Lee EY, Park SY, Han JS, Kim S, Lee JS: Histological grading of IgA nephropathy predicting renal outcome: Revisiting H. S. Lee's glomerular grading system. Nephrol Dial Transplant 2005; 20: 342-348.
17. Lifton RP: Genetic determinants of human hypertension. Proc Natl Acad Sci USA 1995; 92: 8545-8551.
18. Maruyama K, Yoshida M, Nishio H, Shirakawa T, Kawamura T, Tanaka R, Nakamura H, Iijima K, Yoshikawa N: Polymorphisms of renin-angiotensin system genes in childhood IgA nephropathy. Pediatr Nephrol 2001; 16: 350-355.
19. Alamartine E, Sabatier JC, Guerin C, Berliet JM, Berthoux F: Prognostic factors in mesangial IgA glomerulonephritis: An extensive study with univariate and multivariate analyses. Am J Kidney Dis 1991; 18: 12-19.
20. Woo KT, Lau YK, Choong LH, Zhao Y, Tan HB, Fook-Chong S, Tan EK, Yap HK, Wong KS: Polymorphism of renin-angiotensin system genes in IgA nephropathy. Nephrology (Carlton) 2004; 9: 304-309.
21. Hunley TE, Julian BA, Phillips JA, 3rd, Summar ML, Yoshida H, Horn RG, Brown NJ, Fogo A, Ichikawa I, Kon V: Angiotensin converting enzyme gene polymorphism: Potential silencer motif and impact on progression in IgA nephropathy. Kidney Int 1996; 49: 571-577.
22. Goto S, Narita I, Saito N, Watanabe Y, Yamazaki H, Sakatsume M, Shimada H, Nishi S, Ueno M, Akazawa K, Arakawa M, Gejyo F: A(-20)C polymorphism of the angiotensinogen gene and progression of IgA nephropathy. Kidney Int 2002; 62: 980-985. (Pubitemid 35316728)
23. D'Amico G, Minetti L, Ponticelli C, Fellin G, Ferrario F, Barbiano di Belgioioso G, Imbasciati E, Ragni A, Bertoli S, Fogazzi G, et al: Prognostic indicators in idiopathic IgA mesangial nephropathy. Q J Med 1986; 59: 363-378.
24. Silbiger SR, Neugarten J: The impact of gender on the progression of chronic renal disease. Am J Kidney Dis 1995; 25: 515-533.
25. Neugarten J, Acharya A, Silbiger SR: Effect of gender on the progression of nondiabetic renal disease: A meta-analysis. J Am Soc Nephrol 2000; 11: 319-329.
26. Cattran DC, Reich HN, Beanlands HJ, Miller JA, Scholey JW, Troyanov S: The impact of sex in primary glomerulonephritis. Nephrol Dial Transplant 2008; 23: 2247-2253.
27. Shen P, He L, Li Y, Wang Y, Chan M: Natural history and prognostic factors of IgA nephropathy presented with isolated microscopic hematuria in Chinese patients. Nephron Clin Pract 2007; 106:c157-c161.
28. Freire MB, Ji L, Onuma T, Orban T, Warram JH, Krolewski AS: Gender-specific association of M235T polymorphism in angiotensinogen gene and diabetic nephropathy in NIDDM. Hypertension 1998; 31: 896-899.
29. Rogus JJ, Moczulski D, Freire MB, Yang Y, Warram JH, Krolewski AS: Diabetic nephropathy is associated with AGT polymorphism T235: Results of a family-based study. Hypertension 1998; 31: 627-631.
30. Tien KJ, Hsiao JY, Hsu SC, Liang HT, Lin SR, Chen HC, Hsieh MC: Gender-dependent effect of ACE I/D and AGT M235T polymorphisms on the progression of urinary albumin excretion in Taiwanese with type 2 diabetes. Am J Nephrol 2008; 29: 299-308.
31. Miller JA, Anacta LA, Cattran DC: Impact of gender on the renal response to angiotensin II. Kidney Int 1999; 55: 278-285.
32. Reckelhoff JF, Hennington BS, Moore AG, Blanchard EJ, Cameron J: Gender differences in the renal nitric oxide (NO) system: Dissociation between expression of endothelial NO synthase and renal hemodynamic response to NO synthase inhibition. Am J Hypertens 1998; 11: 97-104.